Literature DB >> 11959091

The role of histamine H(1) receptors in late-phase reaction of allergic conjunctivitis.

Keiji Izushi1, Hiroto Nakahara, Nobuyuki Tai, Mitsunobu Mio, Takeshi Watanabe, Chiaki Kamei.   

Abstract

The role of histamine H(1) receptors in the late-phase reaction of allergic conjunctivitis was studied using histamine H(1) receptor-deficient mice. To clarify the eosinophil infiltration, which is a reliable indicator of late-phase reaction, eosinophil peroxidase activity in the conjunctiva was measured. Mice were actively immunized with ovalbumin, and conjunctivitis was induced by topical instillation of ovalbumin. A significantly high eosinophil peroxidase level in the conjunctiva was observed in sensitized wild-type mice, whereas sensitized histamine H(1) receptor-deficient mice showed no significant increase in the conjunctival eosinophil peroxidase level. In addition, the elevation of eosinophil peroxidase level observed in sensitized wild-type mice was significantly antagonized by pretreatment with anti-P-selectin antibody. From these findings, it was concluded that eosinophil infiltration into the conjunctival tissue in late-phase reaction of allergic conjunctivitis is mediated by P-selectin stored in endothelial cells via histamine H(1) receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959091     DOI: 10.1016/s0014-2999(02)01304-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

Review 1.  Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.

Authors:  Gyan P Mishra; Viral Tamboli; Jwala Jwala; Ashim K Mitra
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2011-01

Review 2.  New concepts of histamine receptors and actions.

Authors:  Maria Susana Repka-Ramirez
Journal:  Curr Allergy Asthma Rep       Date:  2003-05       Impact factor: 4.919

3.  Principles of Ocular Pharmacology.

Authors:  Yong Park; Dorette Ellis; Brett Mueller; Dorota Stankowska; Thomas Yorio
Journal:  Handb Exp Pharmacol       Date:  2017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.